机译:预处理的超敏感双链体测序ABL1激酶结构域突变对新诊断的费城染色体阳性急性淋巴细胞白血病
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Hematopathol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Takeda Oncol Cambridge MA USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
Univ Washington Seattle WA 98195 USA;
Penn State Univ Philadelphia PA USA;
Univ Washington Dept Med Div Med Oncol Seattle WA USA;
Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;
机译:预处理的超敏感双链体测序ABL1激酶结构域突变对新诊断的费城染色体阳性急性淋巴细胞白血病
机译:筛选患者ABL1激酶域突变患者患者染色体阳性(pH加)急性淋巴细胞白血病(全部)
机译:ABL1激酶结构域突变和IKZF1缺失对费城染色体阳性(Ph +)急性淋巴细胞白血病(ALL)的60岁以下成人的临床影响:CALGB(Alliance)10001和9665的分子分析
机译:Sentosa Sq白血病面板:靶向下一代测序IVD试验检测白血病患者突变的研究
机译:费城染色体阳性的急性淋巴细胞白血病患者的预后因素。
机译:费城染色体阳性(Ph +)急性淋巴细胞白血病(ALL)在60岁以下成年人中ABL1激酶结构域突变和IKZF1缺失的临床影响:CALGB(Alliance)10001和9665的分子分析
机译:从伊马替尼到第二代酪氨酸激酶抑制剂时代的费城染色体阳性急性淋巴细胞白血病的耐药性和BCR-ABL激酶结构域突变:主要变化在于突变类型,但不涉及突变发生的频率